Company Filing History:

17 out of 677

Eisai Company, Limited

Japan As Represented by General Director of Agency of National Center for Child Health & Development

patents

where one patent can have more than one assignee

Years Active: 1981-2008

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7445892 - Method of testing anticancer agent-sensitivity of tumor cells (2008-11-04),

2. 7148011 - Method of testing for allergic diseases (2006-12-12),

3. 7015241 - Appetite-stimulating agents and remedies for anorexia (2006-03-21),

4. 6986990 - Pollen allergy-related gene 513 (2006-01-17),

5. 5952335 - Fused polycyclic heterocycle derivatives (1999-09-14),

6. 5854274 - Tricyclic heterocyclic sulfonamide and sulfonic ester derivatives (1998-12-29),

7. 5846969 - Tricyclic heterocyclic sulfonamide and sulfonic ester derivatives (1998-12-08),

8. 5840918 - Isoprenyl transferase inhibitors (1998-11-24),

9. 5834462 - Tricyclic heterocyclic sulfonamide and sulfonic ester derivatives (1998-11-10),

10. 5767283 - 7-Amino-1H-indoles (1998-06-16),

11. 5721246 - Heterobicyclic sulfonamide and sulfonic ester derivatives (1998-02-24),

12. 5610320 - Sulfonamide phenyl substituted compounds (1997-03-11),

13. 5610304 - Pyrimidinyl or pyridinyl sulfonamide substituted compounds (1997-03-11),

14. 5434172 - Sulfonamide derivatives (1995-07-18),

15. 5332751 - Pyridine carboxamide compounds which have useful as pharmaceutical (1994-07-26),

Title: The Innovative Contributions of Takeshi Nagasu

Introduction

Takeshi Nagasu is a prominent inventor based in Ibaraki, Japan, known for his significant contributions to the field of medical research. With a total of 18 patents, he has made remarkable strides in developing methods for testing anticancer agents and allergic diseases. His work has the potential to greatly impact patient care and treatment options.

Latest Patents

One of Nagasu's latest patents is a method for testing anticancer agent sensitivity in tumor cells. This innovative approach involves measuring the expression levels of specific genes in tumor cells collected from cancer patients treated with anticancer agents, such as E7070. The method determines susceptibility based on changes in gene expression levels, providing valuable insights into treatment efficacy. Another notable patent focuses on testing for allergic diseases. Utilizing the differential display method, Nagasu identified a gene, '2090-05', whose expression levels differ significantly in eosinophils from patients with atopic dermatitis during exacerbation and remission stages. This discovery opens new avenues for testing and screening therapeutic agents for allergic conditions.

Career Highlights

Throughout his career, Takeshi Nagasu has worked with esteemed organizations, including Eisai Company, Limited and Genox Research, Inc. His experience in these companies has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Nagasu has collaborated with notable colleagues, including Kentaro Yoshimatsu and Hiroshi Yoshino. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Takeshi Nagasu's contributions to medical research through his patents and collaborations highlight his dedication to advancing healthcare solutions. His innovative methods for testing anticancer agents and allergic diseases demonstrate the potential for significant improvements in patient treatment and outcomes.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.